March 7, 2022 — AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice President of Conferences and Events, has passed away after a brave battle with breast cancer. President and CEO Scott Whitaker released the following tribute:

COVID-19 vaccine associated myocarditis.

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of February. This data was drawn from itnonline.com’s 148,000 viewers over the course of the month.

March 4, 2022 — The American College of Radiology (ACR) joins all Americans in calling for an immediate end to fighting in Ukraine enabling medical providers to safely care for the sick and injured and humanitarian organizations to supply necessary aid.

As a first step, we encourage implementation of the “humanitarian corridors” that Ukraine and Russia agree are needed to deliver aid and help civilians exit besieged Ukrainian cities.

March 4, 2022 — AI-based imaging solution developer PaxeraHealth has been awarded a supplier agreement with Premier, Inc. The new agreement allows Premier members, at their discretion, to take advantage of special terms pre-negotiated by Premier for Paxera’s medical imaging solutions, helping members to reduce costs and improve quality of care.

March 4, 2022 — The WTA and Hologic today jointly announced a landmark partnership introducing Hologic as the global title sponsor of the WTA Tour.

The COVID-19 pandemic had a huge impact on the radiology community. Hospitals, doctors’ offices and clinics found themselves overwhelmed with scans at the same time they were modifying workflows to keep healthcare staff and patients safe. Looking ahead to the next phases of the pandemic and beyond, radiologists have the opportunity to re-examine and optimize their workflows, processes and patient care.

March 3, 2022 — Median Technologies announced that the company has filed a 513(g) submission on Feb. 17, 2022, to the United States Food and Drug Administration (FDA) for its iBiopsy Lung Cancer Screening (LCS) AI/ML technology-based end-to-end CADe/CADx Software as Medical Device (SaMD).

March 3, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) deplores the recent invasion of Ukraine that has resulted in the death and injury of a large number of innocent men, women, and children—a horrifying contrast to our work to save lives and improve patient care.

March 2, 2022 — Analyzing breast-cancer tumors with artificial intelligence has the potential to improve healthcare efficiency and outcomes. But doctors should proceed cautiously, because similar technological leaps previously led to higher rates of false-positive tests and over-treatment.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now